{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:53:59Z","timestamp":1770468839695,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T00:00:00Z","timestamp":1757808000000},"content-version":"am","delay-in-days":256,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-12-2-0012"],"award-info":[{"award-number":["W81XWH-12-2-0012"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007333","name":"Alzheimer's Disease Neuroimaging Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021981","name":"Roche Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021981","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jad.2024.08.235","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T03:28:51Z","timestamp":1725938931000},"page":"73-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Interactions between mild depressive symptoms and amyloid pathology on the trajectory of neurodegeneration, cognitive decline, and risk of Alzheimer's disease"],"prefix":"10.1016","volume":"368","author":[{"given":"Xiao-Hui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Chen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Wen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Nan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jad.2024.08.235_bb0005","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jacc.2015.10.057","article-title":"Depressive symptoms and subclinical vascular disease: the role of regular physical activity","volume":"67","author":"Al Mheid","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jad.2024.08.235_bb0010","series-title":"Latent Class Growth Modelling: A Tutorial","author":"Andruff","year":"2009"},{"issue":"10","key":"10.1016\/j.jad.2024.08.235_bb0015","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archgenpsychiatry.2012.43","article-title":"Twenty-year depressive trajectories among older women","volume":"69","author":"Byers","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.08.235_bb0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2009.10.022","article-title":"Depression and Alzheimer\u2019s disease: neurobiological links and common pharmacological targets","volume":"626","author":"Caraci","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.jad.2024.08.235_bb0025","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3233\/JAD-140324","article-title":"Depression in Alzheimer\u2019s disease: epidemiology, mechanisms, and management","volume":"42","author":"Chi","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.jad.2024.08.235_bb0030","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","article-title":"Development and assessment of a composite score for memory in the Alzheimer\u2019s disease neuroimaging initiative (ADNI)","volume":"6","author":"Crane","year":"2012","journal-title":"Brain Imaging Behav."},{"issue":"5","key":"10.1016\/j.jad.2024.08.235_bb0035","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/01.JGP.0000308881.22956.27","article-title":"Outcomes and predictors of late-life depression trajectories in older primary care patients","volume":"16","author":"Cui","year":"2008","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2024.08.235_bb0040","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.neurobiolaging.2010.03.016","article-title":"Integrating ADNI results into Alzheimer\u2019s disease drug development programs","volume":"31","author":"Cummings","year":"2010","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.jad.2024.08.235_bb0045","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jalz.2018.12.009","article-title":"Early versus late MCI: improved MCI staging using a neuropsychological approach","volume":"15","author":"Edmonds","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"8","key":"10.1016\/j.jad.2024.08.235_bb0050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.biopsych.2017.05.024","article-title":"Somatostatin-positive gamma-aminobutyric acid interneuron deficits in depression: cortical microcircuit and therapeutic perspectives","volume":"82","author":"Fee","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2024.08.235_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.8964","article-title":"Longitudinal association of depression symptoms with cognition and cortical amyloid among community-dwelling older adults","volume":"2","author":"Gatchel","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.jad.2024.08.235_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/ADR-200254","article-title":"APOE \u025b4 allele and financial capacity performance in mild Alzheimer\u2019s disease: a pilot study","volume":"5","author":"Giannouli","year":"2021","journal-title":"Journal of Alzheimer\u2019s Disease Reports"},{"key":"10.1016\/j.jad.2024.08.235_bb0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.clinpsy.032408.153550","article-title":"Advances in analysis of longitudinal data","volume":"6","author":"Gibbons","year":"2010","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"4","key":"10.1016\/j.jad.2024.08.235_bb0070","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11682-012-9176-1","article-title":"A composite score for executive functioning, validated in Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment","volume":"6","author":"Gibbons","year":"2012","journal-title":"Brain Imaging Behav."},{"issue":"11","key":"10.1016\/j.jad.2024.08.235_bb0075","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u03b2 PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.jad.2024.08.235_bb0080","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"The Alzheimer\u2019s disease neuroimaging initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"Journal of Magnetic Resonance Imaging: JMRI"},{"issue":"5","key":"10.1016\/j.jad.2024.08.235_bb0085","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-013-1185-7","article-title":"Cerebral amyloid PET imaging in Alzheimer\u2019s disease","volume":"126","author":"Jack","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.jad.2024.08.235_bb0090","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"8","key":"10.1016\/j.jad.2024.08.235_bb0095","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJMoa2310168","article-title":"Biomarker changes during 20 years preceding Alzheimer\u2019s disease","volume":"390","author":"Jia","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jad.2024.08.235_bb0100","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0049124101029003005","article-title":"A SAS procedure based on mixture models for estimating developmental trajectories","volume":"29","author":"Jones","year":"2001","journal-title":"Sociol. Methods Res."},{"issue":"5","key":"10.1016\/j.jad.2024.08.235_bb0105","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamapsychiatry.2016.0004","article-title":"Trajectories of depressive symptoms in older adults and risk of dementia","volume":"73","author":"Kaup","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.08.235_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.0b013e318204a397","article-title":"Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort","volume":"76","author":"Kim","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jad.2024.08.235_bb0115","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/mp.2013.155","article-title":"Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis","volume":"19","author":"Kreisel","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2024.08.235_bb0120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-170991","article-title":"The Alzheimer\u2019s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): modifications and responsiveness in pre-dementia populations. A narrative review","volume":"63","author":"Kueper","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.jad.2024.08.235_bb0125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.0b013e3181e8e8b8","article-title":"Comparing predictors of conversion and decline in mild cognitive impairment","volume":"75","author":"Landau","year":"2010","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jad.2024.08.235_bb0130","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","article-title":"Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI","volume":"32","author":"Landau","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"10.1016\/j.jad.2024.08.235_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020683","article-title":"Framework to construct and interpret latent class trajectory modelling","volume":"8","author":"Lennon","year":"2018","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.jad.2024.08.235_bb0140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.14283\/jpad.2022.13","article-title":"Anxiety and depressive symptoms and cortical amyloid-\u03b2 burden in cognitively unimpaired older adults","volume":"9","author":"Lewis","year":"2022","journal-title":"J. Prev Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.jad.2024.08.235_bb0145","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41398-020-0769-y","article-title":"Shared genetic etiology underlying Alzheimer\u2019s disease and major depressive disorder","volume":"10","author":"Lutz","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2024.08.235_bb0150","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.biopsych.2020.06.017","article-title":"Late-life depression is associated with reduced cortical amyloid burden: findings from the Alzheimer\u2019s disease neuroimaging initiative depression project","volume":"89","author":"Mackin","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.235_bb0155","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3233\/JAD-170225","article-title":"Depressive symptoms are associated with progression to dementia in patients with amyloid-positive mild cognitive impairment","volume":"58","author":"Moon","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.jad.2024.08.235_bb0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41380-020-0727-3","article-title":"Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders","volume":"26","author":"Pr\u00e9vot","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2024.08.235_bb0165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/156720509788929273","article-title":"Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort","volume":"6","author":"Risacher","year":"2009","journal-title":"Curr. Alzheimer Res."},{"issue":"3","key":"10.1016\/j.jad.2024.08.235_bb0170","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2011.11.009","article-title":"Alzheimer\u2019s disease pathology does not mediate the association between depressive symptoms and subsequent cognitive decline","volume":"9","author":"Royall","year":"2013","journal-title":"Alzheimers Dement."},{"issue":"10284","key":"10.1016\/j.jad.2024.08.235_bb0175","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jad.2024.08.235_bb0180","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"issue":"236","key":"10.1016\/j.jad.2024.08.235_bb0185","doi-asserted-by":"crossref","first-page":"236re4","DOI":"10.1126\/scitranslmed.3008169","article-title":"An antidepressant decreases CSF A\u03b2 production in healthy individuals and in transgenic AD mice","volume":"6","author":"Sheline","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jad.2024.08.235_bb0190","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jad.2019.08.053","article-title":"Usefulness of the 15-item geriatric depression scale (GDS-15) for classifying minor and major depressive disorders among community-dwelling elders","volume":"259","author":"Shin","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.jad.2024.08.235_bb0195","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.jad.2024.08.235_bb0200","article-title":"Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer's disease","volume":"7","author":"Tissot","year":"2021","journal-title":"Alzheimer's & dementia (New York, N. Y.)"},{"issue":"3","key":"10.1016\/j.jad.2024.08.235_bb0205","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jalz.2010.03.008","article-title":"Update on the biomarker core of the Alzheimer\u2019s disease neuroimaging initiative subjects","volume":"6","author":"Trojanowski","year":"2010","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.jad.2024.08.235_bb0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41398-024-02739-9","article-title":"Association of amyloid-beta with depression or depressive symptoms in older adults without dementia: a systematic review and meta-analysis","volume":"14","author":"Twait","year":"2024","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.08.235_bb0215","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41398-022-01910-4","article-title":"sTREM2 mediates the associations of minimal depressive symptoms with amyloid pathology in prodromal Alzheimer\u2019s disease: the CABLE study","volume":"12","author":"Wang","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.08.235_bb0220","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41398-022-01910-4","article-title":"sTREM2 mediates the associations of minimal depressive symptoms with amyloid pathology in prodromal Alzheimer\u2019s disease: the CABLE study","volume":"12","author":"Wang","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2024.08.235_bb0225","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jalz.2010.03.007","article-title":"The Alzheimer\u2019s disease neuroimaging initiative: progress report and future plans","volume":"6","author":"Weiner","year":"2010","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.jad.2024.08.235_bb0230","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.jalz.2013.05.1769","article-title":"The Alzheimer\u2019s disease neuroimaging initiative: a review of papers published since its inception","volume":"9","author":"Weiner","year":"2013","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.jad.2024.08.235_bb0235","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jalz.2014.11.001","article-title":"2014 update of the Alzheimer\u2019s disease neuroimaging initiative: a review of papers published since its inception","volume":"11","author":"Weiner","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.jad.2024.08.235_bb0240","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3233\/JAD-201582","article-title":"Insomnia moderates the relationship between amyloid-\u03b2 and cognitive decline in late-life adults without dementia","volume":"81","author":"Xu","year":"2021","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.jad.2024.08.235_bb0245","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.biopsych.2020.07.004","article-title":"Amyloid pathologies modulate the associations of minimal depressive symptoms with cognitive impairments in older adults without dementia","volume":"89","author":"Xu","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2024.08.235_bb0250","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.biopsych.2020.07.004","article-title":"Amyloid pathologies modulate the associations of minimal depressive symptoms with cognitive impairments in older adults without dementia","volume":"89","author":"Xu","year":"2021","journal-title":"Biol. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724014678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724014678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:37:14Z","timestamp":1762249034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724014678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":50,"alternative-id":["S0165032724014678"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.08.235","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions between mild depressive symptoms and amyloid pathology on the trajectory of neurodegeneration, cognitive decline, and risk of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.08.235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}